Coherus Oncology, Inc. - Common Stock (CHRS)
Seasonality Analysis
Coherus Oncology, Inc. - Common Stock Annual Seasonality Statistics
Coherus Oncology, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 4.40% | Weak | |
| February | -1.07% | Weak | |
| March | -0.63% | Weak | |
| April | -0.63% | Weak | |
| May | -5.83% | Very Weak | |
| June | -1.98% | Very Weak | |
| July | 7.67% | Moderate | |
| August BEST | 12.83% | Very Strong | |
| September WORST | -9.19% | Very Weak | |
| October | -4.02% | Very Weak | |
| November | 0.70% | Weak | |
| December | 3.34% | Weak |
Coherus Oncology, Inc. - Common Stock 2026 vs Historical Pattern
Coherus Oncology, Inc. - Common Stock Interactive Seasonality Chart
Coherus Oncology, Inc. - Common Stock Pattern Scanner
Coherus Oncology, Inc. - Common Stock Seasonal Historical Performance
About Coherus Oncology, Inc. - Common Stock (CHRS) Seasonality
Coherus Oncology, Inc. - Common Stock (CHRS) has been analyzed using 12 years of historical data to identify seasonal patterns. Classified under Stocks, Coherus Oncology, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Coherus Oncology, Inc. - Common Stock is historically August, with an average return of 12.83% and a win rate of 82%. Conversely, September tends to be the weakest month, averaging -9.19% return.
Looking at the full calendar year, Coherus Oncology, Inc. - Common Stock has an average annual return of 5.61% with an overall monthly win rate of 44.1%. Out of 12 months, 5 typically show positive average returns.
The seasonal pattern for Coherus Oncology, Inc. - Common Stock has a consistency score of 44.4 (Poor), based on 13 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Coherus Oncology, Inc. - Common Stock Seasonality FAQ
What is the best month to buy Coherus Oncology, Inc. - Common Stock (CHRS)?
Historically, August has been the best month for Coherus Oncology, Inc. - Common Stock, with an average return of 12.83% and a win rate of 82%. However, past performance does not guarantee future results.
What is the worst month for Coherus Oncology, Inc. - Common Stock (CHRS)?
Based on historical data, September has been the weakest month for Coherus Oncology, Inc. - Common Stock, with an average return of -9.19%. This is a historical observation and does not guarantee future results.
How reliable is CHRS seasonality data?
The seasonality analysis for Coherus Oncology, Inc. - Common Stock is based on 12 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Coherus Oncology, Inc. - Common Stock seasonality in my trading?
Use Coherus Oncology, Inc. - Common Stock (CHRS) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.